Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Ocular Therapeutix Inc
About OCUL
Ocular Therapeutix, Inc. is an integrated biopharmaceutical company. AXPAXLI, also known as OTX-TKI, the Company's investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on its ELUTYX bioresorbable hydrogel-based formulation technology. Its pipeline also leverages the ELUTYX technology in its commercial product DEXTENZA, a corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery in adults and pediatric patients, and ocular itching associated with allergic conjunctivitis in adults and pediatric patients aged two years or older, and in its investigational product candidate PAXTRAVA, which is a travoprost intracameral hydrogel for the treatment of open-angle glaucoma or ocular hypertension. The ELUTYX technology provides delivery solutions for durable therapies for wet age-related macular degeneration (wet AMD), NPDR, DME, proliferative diabetic retinopathy, retinal vein occlusion, and other diseases.
Find out what a historical investment in Ocular Therapeutix Inc would be worth today using our OCUL stock calculator.
Market Capitalisation
$2.01B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.37M
High today
$9.36
Low today
$9.04
Open price
$9.29
52-week high
$16.44
52-week low
$6.23
Ready to start your investing journey with Stake?
Open an accountHow do I buy OCUL shares in Australia?
Buying OCUL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Ocular Therapeutix Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in OCUL
What is the ticker symbol of Ocular Therapeutix Inc?
The ticker symbol for Ocular Therapeutix Inc is OCUL.
How much is one share of OCUL?
One share of OCUL is valued at $9.19 as of 16 May 2026.
What is the market capitalisation of Ocular Therapeutix Inc OCUL?
As of 16 May 2026 Ocular Therapeutix Inc has a market cap of $2.01B.
What is the 52-week high for Ocular Therapeutix Inc stock?
The Ocular Therapeutix Inc 52-week high stock price is $16.44.
What is the 52-week low for Ocular Therapeutix Inc stock?
The Ocular Therapeutix Inc 52-week low stock price is $6.23.
Can I buy OCUL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy OCUL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in OCUL on Stake
- Buy OCUL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of OCUL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
OCUL related stocks